» Articles » PMID: 36013278

MicroRNAs As Regulators of Cancer Cell Energy Metabolism

Overview
Journal J Pers Med
Date 2022 Aug 26
PMID 36013278
Authors
Affiliations
Soon will be listed here.
Abstract

To adapt to the tumor environment or to escape chemotherapy, cancer cells rapidly reprogram their metabolism. The hallmark biochemical phenotype of cancer cells is the shift in metabolic reprogramming towards aerobic glycolysis. It was thought that this metabolic shift to glycolysis alone was sufficient for cancer cells to meet their heightened energy and metabolic demands for proliferation and survival. Recent studies, however, show that cancer cells rely on glutamine, lipid, and mitochondrial metabolism for energy. Oncogenes and scavenging pathways control many of these metabolic changes, and several metabolic and tumorigenic pathways are post-transcriptionally regulated by microRNA (miRNAs). Genes that are directly or indirectly responsible for energy production in cells are either negatively or positively regulated by miRNAs. Therefore, some miRNAs play an oncogenic role by regulating the metabolic shift that occurs in cancer cells. Additionally, miRNAs can regulate mitochondrial calcium stores and energy metabolism, thus promoting cancer cell survival, cell growth, and metastasis. In the electron transport chain (ETC), miRNAs enhance the activity of apoptosis-inducing factor (AIF) and cytochrome c, and these apoptosome proteins are directed towards the ETC rather than to the apoptotic pathway. This review will highlight how miRNAs regulate the enzymes, signaling pathways, and transcription factors of cancer cell metabolism and mitochondrial calcium import/export pathways. The review will also focus on the metabolic reprogramming of cancer cells to promote survival, proliferation, growth, and metastasis with an emphasis on the therapeutic potential of miRNAs for cancer treatment.

Citing Articles

The crosstalk between non-coding RNAs and oxidative stress in cancer progression.

Sun Q, Lei X, Yang X Genes Dis. 2025; 12(3):101286.

PMID: 40028033 PMC: 11870203. DOI: 10.1016/j.gendis.2024.101286.


Involvement of miR775 in the Post-Transcriptional Regulation of Fructose-1,6-Bisphosphate Aldolase in Maize ( L.) Leaves Under Hypoxia.

Fedorin D, Khomutova A, Eprintsev A, Igamberdiev A Int J Mol Sci. 2025; 26(3).

PMID: 39940636 PMC: 11816697. DOI: 10.3390/ijms26030865.


Linking microRNA to metabolic reprogramming and gut microbiota in the pathogenesis of colorectal cancer (Review).

Bin Wan Mohd Nor W, Kwong S, Fuzi A, Said N, Jamil A, Lee Y Int J Mol Med. 2025; 55(3).

PMID: 39820715 PMC: 11759585. DOI: 10.3892/ijmm.2025.5487.


MicroRNAs and their role in breast cancer metabolism (Review).

Lee W, Yeo B, Mahmud R, Tan G, Wahid M, Cheah Y Int J Oncol. 2024; 66(1).

PMID: 39635852 PMC: 11684793. DOI: 10.3892/ijo.2024.5713.


Glucose metabolism in glioma: an emerging sight with ncRNAs.

Rong J, Wang Q, Li T, Qian J, Cheng J Cancer Cell Int. 2024; 24(1):316.

PMID: 39272133 PMC: 11395608. DOI: 10.1186/s12935-024-03499-8.


References
1.
Krulwich T . Na+/H+ antiporters. Biochim Biophys Acta. 1983; 726(4):245-64. DOI: 10.1016/0304-4173(83)90011-3. View

2.
Zhang S, Liu X, Liu J, Guo H, Xu H, Zhang G . PGC-1 alpha interacts with microRNA-217 to functionally regulate breast cancer cell proliferation. Biomed Pharmacother. 2016; 85:541-548. DOI: 10.1016/j.biopha.2016.11.062. View

3.
Zhao Y, Li W, Li M, Hu Y, Zhang H, Song G . Targeted inhibition of MCT4 disrupts intracellular pH homeostasis and confers self-regulated apoptosis on hepatocellular carcinoma. Exp Cell Res. 2019; 384(1):111591. DOI: 10.1016/j.yexcr.2019.111591. View

4.
Crompton M, Kunzi M, Carafoli E . The calcium-induced and sodium-induced effluxes of calcium from heart mitochondria. Evidence for a sodium-calcium carrier. Eur J Biochem. 1977; 79(2):549-58. DOI: 10.1111/j.1432-1033.1977.tb11839.x. View

5.
Guo Z, Maki M, Ding R, Yang Y, Zhang B, Xiong L . Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues. Sci Rep. 2014; 4:5150. PMC: 5381490. DOI: 10.1038/srep05150. View